Gary Becker spent 30 years as a health insurance and risk management consultant. Then the FDA called. He folded faster than a lawn chair at a funeral.
Becker runs ScriptSourcing, a Bonita Springs, Florida outfit that pitched international prescription programs to self-funded employer health plans. The FDA had learned of two alleged incidents where its imported drugs harmed patients. Scrutiny arrived. Loyalty left.
Becker told agents that CANARX had handed him a "road map" for importing drugs. He then supplied a spreadsheet of transactions with CANARX from 2021 to 2026. Five years of bookkeeping, delivered like a casserole to a grieving neighbor.
The Howard brothers now face charges. John Howard was arrested. Bob Howard, the company president, is wanted. It is the first U.S. criminal case against an alternative funding program.
Consider the business model. Employers wanted cheaper drugs. Middlemen promised Canadian ones. The FDA says personal importation does not make this legal. Becker called the same plan compliant, via an employee who boasted of 2,000 brand-name specialty medications and 3,000 health plans. Impressive numbers. Terrible alibi.
The roadmap was a trade secret. Then it became Exhibit A.
Retail traders love this sort of thing. They call it "disruption." They want to buy the dip in whatever sells pills out of a Florida strip mall. Then a 35-page affidavit from FDA special agent Dustin Dobbs lands, and the disruptor is a witness.
Everyone in this story is presumed innocent until proven otherwise, including the Howards. Becker, meanwhile, appears presumed useful.
Gary Becker rolled on his friends before the FDA finished its coffee. Somewhere, a golden retriever is taking notes.
Photo by Etactics Inc on Unsplash

Leave a Comment